Adaptive immunity, antibodies and gene rearrangement Flashcards
(55 cards)
When did adaptive immunity first evolve?
500 million yeas ago
How do we know that adaptive immunity of BCR, TCR and MHC were successful?
Because every other species from jawed vertebrates onwards has adaptive immunity meaning this was a very successful adaptation.
What were the names of the fish that did not have BCR, TCR and MCH and what did they have instead?
The two species were called Hagfish and Lamprey eels and they had variable lymphocyte receptors (VLR).
What is transposition (jumping genes)?
Transposition occurs when a gene or DNA sequence changes its position within the genome. This means the section of DNA is either moved to a new location or copied and inserted elsewhere. It is not always removed completely from the genome.
What are the two key elements of transposition and what do they do?
- Transposase or recombinase = Enzyme thats cuts and repositions the gene.
- Recognition sequences (RS) = These are short base sequence of DNA located at the end of the gene segment, telling the tranposase to cut the DNA. (Recognised by the transpose)
What is adaptive immunity known for?
A system that changes with time (adapt) to respond faster and more effectively to a pathogen.
What is immune memory?
Immune memory is a key feature of adaptive immunity that provides life-long protection
But how do your body know how to respond to specific pathogens?
- Billions of lympoctes (B and T cells) are produced randomly before birth. Each of these cells are specific to the antigen.
2.
Why is BCR and TCR the only genetic region in your entire genome that can rearrange?
Because Ig and TCR loci are regions in the DNA that code for antibodies (Ig) and T-cell receptors (TCR). The regions are made up of segments of DNA and each segment has RS at their ends.
What is IG domain?
Repeating protein unit that make antibody.
How is the IG domain arranged?
This is made up of two anti-parallel B pleated sheets that are joined together by a central disulphide bond. The B sheets are made up of B strands.
Explain the IG domain as a hand analogy.
The 2 pleated b sheets are the hands, and in between is the disulphide bond. The fingers are the loops at the end, called CDRs and they are not constrained (flexible).
Explain why the loops at the end of the IG domain is flexible.
It’s flexible because their
amino acid sequences can vary without disrupting the
overall structure of the domain. This means that the amino acids change their sequence depending on the different type of antigen it needs to bind to.
What is β-barrel?
Refers to the IG protein fold meaning how the IG domain folds and take the 3D structure.
How is the Ig domain and antibody related?
Ig domain is a key structure that makes up the antibody.
Describe the antibody structure.
Antibody is Y shaped made up of 2 arms and a stem. Each arm is made of up 2 chains: heavy chain and light chain and linked together by disulphide bonds. This L—s-s—H is one arm.
What does one complete arm of the antibody called?
Fab
Where are the two identical antigen binding sites?
At the tip of the arms.
What are the heavy and light chains made up of?
Multiple IG domains.
What is the stem of the antibody made up of and what is another name for it?
It is made up of heavy chains specifically CH2 and CH3 , and another name for the stem is called the the invariant effector region.
How are the classes of the antibody defined by?
They are defined by the H chain gene used on the stem / invariant effector region.
What are the 5 classes of antibodies?
GAMED - IgG, IgA, IgM, IgE, IgD.
Where is IgG found in and what are the 5 key functions?
This antibody is found in blood, its the most abundant, produced after class switching from IgM, fixes complement, Crosses the placenta to protect babies (neonatal immunity), Provides long-term protection.
Where is IgA found in and what does it do?
It is found in Blood and mucosal
secretions such as in
tears, breast milk, gut,
genitourinary tract. The main function is to provide gut immunity
to neonates (newborn babies) who don’t have their own antibodies yet.